Work

Contribution of the Conserved Amino Acids of the Melanocortin-4 Receptor in d-[Nle4,Phe7]-α-Melanocyte-stimulating Hormone Binding and Signaling

Year: 2007
Type: article
Abstract: Melanocortin 4 receptor (MC4R) plays an important role in the regulation of food intake and body weight. To determine the molecular basis of human MC4R (hMC4R) responsible for α-melanocortin-stimulating hormone (α-MSH) binding, in this study, we utilized both receptor domain exchange and site-directed mutagenesis studies to investigate the molecular determinants of hMC4R responsible for α-MSH binding and signaling. α-MSH is a potent agonist at hMC4R but not at hMC2R. Cassette substitutions of the second, third, fourth, fifth, and sixth transmembrane regions (TM) of the hMC4R with the homologous regions of hMC2R were performed and α-MSH binding and signaling were examined. Our results indicate that each chimeric receptor was expressed at the cell surface and the expression levels remain similar to that of the wild-type receptor. The cassette substitutions of the second, fourth, fifth, and sixth TMs of the hMC4R with homologous regions of the hMC2R did not significantly alter α-MSH binding affinity and potency except substitution of the TM3 of the hMC4R, suggesting that the conserved residues in TMs of the hMC4R are crucial for α-MSH binding and signaling. Further mutagenesis studies indicate that conserved residues Glu100 in TM2, Asp122, Asp126 in TM3 and Trp258, Phe261, His264 in TM6 are involved in α-MSH binding and signaling. In conclusion, our results suggest that the conserved residues in the TM2, TM3, and TM6 of the hMC4R are responsible for α-MSH binding and signaling. Melanocortin 4 receptor (MC4R) plays an important role in the regulation of food intake and body weight. To determine the molecular basis of human MC4R (hMC4R) responsible for α-melanocortin-stimulating hormone (α-MSH) binding, in this study, we utilized both receptor domain exchange and site-directed mutagenesis studies to investigate the molecular determinants of hMC4R responsible for α-MSH binding and signaling. α-MSH is a potent agonist at hMC4R but not at hMC2R. Cassette substitutions of the second, third, fourth, fifth, and sixth transmembrane regions (TM) of the hMC4R with the homologous regions of hMC2R were performed and α-MSH binding and signaling were examined. Our results indicate that each chimeric receptor was expressed at the cell surface and the expression levels remain similar to that of the wild-type receptor. The cassette substitutions of the second, fourth, fifth, and sixth TMs of the hMC4R with homologous regions of the hMC2R did not significantly alter α-MSH binding affinity and potency except substitution of the TM3 of the hMC4R, suggesting that the conserved residues in TMs of the hMC4R are crucial for α-MSH binding and signaling. Further mutagenesis studies indicate that conserved residues Glu100 in TM2, Asp122, Asp126 in TM3 and Trp258, Phe261, His264 in TM6 are involved in α-MSH binding and signaling. In conclusion, our results suggest that the conserved residues in the TM2, TM3, and TM6 of the hMC4R are responsible for α-MSH binding and signaling. Obesity is a common and rapidly growing health problem in the United States and worldwide (1Kopelman P.G. Nature. 2000; 404: 635-643Crossref PubMed Scopus (3756) Google Scholar, 2Flegal K.M. Carroll M.D. Ogden C.L. Johnson C.L. J. Am. Med. Assoc. 2002; 288: 1723-1727Crossref PubMed Scopus (5409) Google Scholar, 3Allison D.B. Fontaine K.R. Manson J.E. Stevens J. VanItallie T.B. J. Am. Med. Assoc. 1999; 282: 1530-1538Crossref PubMed Scopus (1550) Google Scholar, 4Zimmermann-Belsing T. Feldt-Rasmussen U. Endocrinology. 2004; 145: 1501-1502Crossref PubMed Scopus (37) Google Scholar, 5Rugg K. Nurs. Times. 2004; 100: 28-30PubMed Google Scholar, 6Kowalski T.J. Appetite. 2004; 42: 11-14Crossref PubMed Scopus (11) Google Scholar, 7Damcott C.M. Moffett S.P. Feingold E. Barmada M.M. Marshall J.A. Hamman R.F. Ferrell R.E. Metabolism. 2004; 53: 303-309Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar, 8Geller F. Reichwald K. Dempfle A. Illig T. Vollmert C. Herpertz S. Siffert W. Platzer M. Hess C. Gudermann T. Biebermann H. Wichmann H.E. Schafer H. Hinney A. Hebebrand J. Am. J. Hum. Genet. 2004; 74: 572-581Abstract Full Text Full Text PDF PubMed Scopus (182) Google Scholar). The melanocortin-4 receptor (MC4R) 2The abbreviations used are: hMC4R, human melanocortin-4 receptor; MCR, melanocortin receptor; NDP-MSH, d-[Nle4,Phe7]-α-melanocyte-stimulating hormone; TM, transmembrane domains; FACs, flow cytometry; WT, wild type; ACTH, adrenocorticotropic hormone. plays a key role in the regulation of food intake and body weight. Mutations of human MC4R (hMC4R) are the most common monogenic cause of human obesity described to date, accounting for up to 6% of all cases of severe early onset obesity (9Lubrano-Berthelier C. Cavazos M. Dubern B. Shapiro A. Stunff C.L. Zhang S. Picart F. Govaerts C. Froguel P. Bougneres P. Clement K. Vaisse C. Ann. N. Y. Acad. Sci. 2003; 994: 49-57Crossref PubMed Scopus (98) Google Scholar, 10Farooqi I.S. Keogh J.M. Yeo G.S. Lank E.J. Cheetham T. O'Rahilly S. N. Engl. J. Med. 2003; 348: 1085-1095Crossref PubMed Scopus (1340) Google Scholar, 11Farooqi I.S. Yeo G.S. Keogh J.M. Aminian S. Jebb S.A. Butler G. Cheetham T. O'Rahilly S. J. Clin. Investig. 2000; 106: 271-279Crossref PubMed Scopus (665) Google Scholar). MC4R is a seven-transmembrane G protein-coupled receptor expressed mainly in the hypothalamus (12Huszar D. Lynch C.A. Fairchild-Huntress V. Dunmore J.H. Fang Q. Berkemeier L.R. Gu W. Kesterson R.A. Boston B.A. Cone R.D. Smith F.J. Campfield L.A. Burn P. Lee F. Cell. 1997; 88: 131-141Abstract Full Text Full Text PDF PubMed Scopus (2610) Google Scholar, 13Fan W. Boston B.A. Kesterson R.A. Hruby V.J. Cone R.D. Nature. 1997; 385: 165-168Crossref PubMed Scopus (1690) Google Scholar, 14Giraudo S.Q. Billington C.J. Levine A.S. Brain Res. 1998; 809: 302-306Crossref PubMed Scopus (171) Google Scholar, 15Cone R.D. Trends Endocrinol. Metab. 1999; 10: 211-216Abstract Full Text Full Text PDF PubMed Scopus (307) Google Scholar, 16Fisher S.L. Yagaloff K.A. Burn P. Int. J. Obes. Relat. Metab Disord. 1999; 23: 54-58Crossref PubMed Scopus (28) Google Scholar). The endogenous agonist, α-melanocyte-stimulating hormone (α-MSH), activates MC4R and inhibits food intake, whereas agouti-related protein, the endogenous antagonist, inhibits MC4R action and induces food intake (13Fan W. Boston B.A. Kesterson R.A. Hruby V.J. Cone R.D. Nature. 1997; 385: 165-168Crossref PubMed Scopus (1690) Google Scholar, 17Fong T.M. Mao C. MacNeil T. Kalyani R. Smith T. Weinberg D. Tota M.R. Van der Ploeg L.H. Biochem. Biophys. Res. Commun. 1997; 237: 629-631Crossref PubMed Scopus (203) Google Scholar, 18Ollmann M.M. Wilson B.D. Yang Y.K. Kerns J.A. Chen Y. Gantz I. Barsh G.S. Science. 1997; 278: 135-138Crossref PubMed Scopus (1577) Google Scholar). MC4R is a member of the family of G protein-coupled receptors and consists of a single polypeptide featuring seven α-helical transmembrane domains (TMs), an extracellular N terminus, three extracellular loops, three intracellular loops, and an intracellular C terminus. Pharmacologic studies have identified that the tripeptide Phe7-Arg8-Trp9 in α-MSH is the minimal active fragment retaining biological activity at MC4R (85). The ligand receptor interaction between α-MSH and MC4R has been extensively studied based on the model generated by computer (19Yang Y.K. Fong T.M. Dickinson C.J. Mao C. Li J.Y. Tota M.R. Mosley R. Van Der Ploeg L.H. Gantz I. Biochemistry. 2000; 39: 14900-14911Crossref PubMed Scopus (164) Google Scholar, 20Yang Y. Chen M. Lai Y. Gantz I. Georgeson K.E. Harmon C.M. J. Biol. Chem. 2002; 277: 20328-20335Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar, 21Haskell-Luevano C. Cone R.D. Monck E.K. Wan Y.P. Biochemistry. 2001; 40: 6164-6179Crossref PubMed Scopus (138) Google Scholar, 22Fleck B.A. Chen C. Yang W. Huntley R. Markison S. Nickolls S.A. Foster A.C. Hoare S.R. Biochemistry. 2005; 44: 14494-14508Crossref PubMed Scopus (26) Google Scholar, 23Hogan K. Peluso S. Gould S. Parsons I. Ryan D. Wu L. Visiers I. J. Med. Chem. 2006; 49: 911-922Crossref PubMed Scopus (30) Google Scholar, 24Pogozheva I.D. Chai B.X. Lomize A.L. Fong T.M. Weinberg D.H. Nargund R.P. Mulholland M.W. Gantz I. Mosberg H.I. Biochemistry. 2005; 44: 11329-11341Crossref PubMed Scopus (80) Google Scholar). However, detailed information about ligand receptor interaction between α-MSH and MC4R remains unclear. In this study, we utilize both chimeric receptor and site-directed mutagenesis study to determine the molecular basis of hMC4R responsible for α-MSH binding and signaling. Both hMC4R and hMC2R are subtypes of the melanocortin receptor family and share a number of structural, functional, and pharmacological similarities. In the putative TM regions, both hMC4R and hMC2R show overall identities of 58% and similarities of 91%. They have high binding affinities for agonist ACTH and antagonist agouti signaling protein. However, hMC4R and hMC2R exhibit a number of pharmacologic differences (25Yang Y.K. Ollmann M.M. Wilson B.D. Dickinson C. Yamada T. Barsh G.S. Gantz I. Mol. Endocrinol. 1997; 11: 274-280Crossref PubMed Scopus (124) Google Scholar, 26Yang Y.K. Dickinson C. Lai Y.M. Li J.Y. Gantz I. Am. J. Physiol. 2001; 281: R1877-R1886Google Scholar, 27Yang Y.K. Thompson D.A. Dickinson C.J. Wilken J. Barsh G.S. Kent S.B. Gantz I. Mol. Endocrinol. 1999; 13: 148-155Crossref PubMed Scopus (162) Google Scholar). Endogenous agonists, α-MSH, β-MSH, and γ-MSH, are potent agonists at MC4R but not at hMC2R. Agouti-related protein is a potent antagonist for hMC4R but not at MC2R. Therefore, MC2R is a good candidate to determine the molecular determinants of hMC4R responsible for α-MSH binding and signaling. Our results indicate that six conserved amino acid residues in TM2, TM3, and TM6 of the hMC4R are crucial for MSH binding and signaling. [Nle4-d-Phe7]-MSH (NDP-α-MSH), an analogue of α-MSH, was purchased from Peninsula Laboratories (Belmont, CA). 3-Isobutylmethylxanthine was from Sigma and [125I]NDP-MSH was from Amersham Biosciences. Dulbecco's modified Eagle's medium and Lipofectamine were from Invitrogen. Construction of Melanocoritn Receptor Chimeric Receptors—The amino acid sequences of the hMC2R and hMC4R were examined by hydrophobicity plot (Genetics Computer Group, Inc., Madison, WI) and manually by comparing their sequences to a previously published alignment of seven transmembrane G protein-coupled receptor α-helices (28Baldwin J.M. EMBO J. 1993; 12: 1693-1703Crossref PubMed Scopus (892) Google Scholar). A sequence comparison of the transmembrane domains of the hMC2R and hMC4R is shown in Fig. 1. The chimeras utilized in these studies are schematically diagramed in Fig. 2. The chimeric receptors were constructed by PCR using Pfu polymerase (Stratagene, La Jolla, CA) (29Yang Y.K. Dickinson C.J. Zeng Q. Li J.Y. Thompson D.A. Gantz I. J. Biol. Chem. 1999; 274: 14100-14106Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar). The human MC4R served as templates. During an initial round of PCR, partial-length receptor fragments were generated. The sequence of one of the PCR primer oligonucleotides consisted of the transmembrane domain of interest, which was then coupled to a portion of the extracellular domain required to form the chimeric receptor. The second oligonucleotide primer consisted of the 5′ or 3′ end of the MC4R. Receptor fragments were separated by agarose gel electrophoresis and used in a second round of PCR in which full-length chimeric receptor constructs were assembled by cycling the appropriate fragments together for 10 cycles prior to adding both 5′ and 3′ receptor primers. The chimeric receptors were subcloned into the eukaryotic expression vector pcDNA 3.1 (Invitrogen).FIGURE 2Schematic representation of the chimeric hMCRs utilized in these studies. A schematic depicts the seven transmembrane structures of the “wild-type” (WT) MC4R (drawn with heavy lines) and MC2R (drawn with thin lines). B depicts the structure of the chimeric MC4R.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Site-directed Mutagenesis of hMC4R—Single mutations was constructed using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). The entire coding region of the mutated receptors was sequenced to confirm that the desired mutation sequences were present and that no sequence errors had been introduced by University of Alabama, Birmingham Sequence Core. The mutated receptors are shown in Fig. 5. The mutant receptors were then subcloned into the eukaryotic expression vector pCDNA 3.1 (Invitrogen). Cell Culture and Transfection—The OS3 cell line was used for hMC4R, hMC2R, and chimeric receptor transfection. The cells transfected with receptor were cultured in Dulbecco's modified Eagle's medium containing 10% bovine fetal serum and HEPES. at were and the receptor constructs were transfected into cells using Lipofectamine Y. Dickinson C. C. Gantz I. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). were performed using the previously described (19Yang Y.K. Fong T.M. Dickinson C.J. Mao C. Li J.Y. Tota M.R. Mosley R. Van Der Ploeg L.H. Gantz I. Biochemistry. 2000; 39: 14900-14911Crossref PubMed Scopus (164) Google Scholar). of the cells were with from to in of minimal medium containing bovine serum and of for The binding were by the and the cells with minimal medium containing bovine serum The cells were then with and the in the was in an binding was by the of on the cells in the of binding was by from are as and was using a binding kit Amersham cell was and cells were with of containing the melanocortin agonist for at in the of The was by adding was as previously to the kit (25Yang Y.K. Ollmann M.M. Wilson B.D. Dickinson C. Yamada T. Barsh G.S. Gantz I. Mol. Endocrinol. 1997; 11: 274-280Crossref PubMed Scopus (124) Google Scholar). Receptor C.L. J. Cell. Biochem. 2004; PubMed Scopus Google cells were using and with of cells were and with in The cells were with 10 number in for this the to receptors at the cell The cells were by The cell were in of containing Inc., was performed on a cell six with a The results were using the CA). was performed in three The of the of binding and was to a with a using CA). were expressed as was by of with to of the TMs of the hMC4R with the of the hMC2R on binding affinity of at wild-type and receptors was examined. shown in Fig. high affinity binding at wild-type hMC4R but not at hMC2R. To the of to hMC4R or was at hMC4R but not at hMC2R as To investigate which regions of the hMC4R are responsible for binding and a was used to regions of the hMC4R responsible for Cassette substitutions of the TM2, TM3, and TM6 of the hMC4R with homologous regions of the hMC2R were performed The and TMs were not for our that were not important in binding C. Cone R.D. Monck E.K. Wan Y.P. Biochemistry. 2001; 40: 6164-6179Crossref PubMed Scopus (138) Google Scholar, Y. Dickinson C. C. Gantz I. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar, C. S. J.A. C. Gantz I. Hruby V.J. Google Scholar). To determine chimeric receptor are expressed at the cell surface and to the receptor expression we have utilized the to the receptor The sequence was into the N of the hMC4R using polymerase The protein is an amino acid and has been used to determine protein expression by flow Johnson T.M. Biochemistry. 1999; PubMed Scopus Google Scholar). Our results indicate that by cells the and chimeric receptors by The protein expression levels of the chimeric receptors no with that of the wild-type receptor domain of hMC4R on binding and with with no with no in a To the binding affinity of ligand at these chimeric an of to was performed Our results indicate that these chimeric receptors did not significantly alter binding affinity except for the chimeric their are in 1. To the of to chimeric was Our results indicate that in a at these chimeric receptors and their are shown in 1. of the hMC4R TM3 with the region of the hMC2R significantly binding affinity and are shown in 1. Mutations of the in TM2, TM3, and TM6 of the hMC4R for and substitutions of the TM2, TM3, and TM6 of the hMC4R with the regions of the hMC2R did not significantly alter or suggesting that a conserved amino acid of the MC4R TMs crucial for binding and on the model of and have been to involved in MSH binding and receptor C. S. J.A. C. Gantz I. Hruby V.J. Google the conserved and amino acid residues in TMs of the hMC4R were in this The conserved amino and are not MSH is a acid and the receptor transmembrane the conserved and amino acid residues in the region of the transmembrane regions of hMC4R are for binding and signaling. A sequence alignment of hMC4R and hMC2R were and amino acid residues in TM2, TM3, and TM6 are identified conserved between hMC4R and hMC2R in the regions of the transmembrane regions of hMC4R To determine these amino acid residues are involved in binding and these residues were mutated with and binding affinity and potency were Our results indicate that all of the mutant receptors were expressed at the cell surface and their are shown in 2. The expression levels of mutations and are that of the The protein expression levels of mutations and are not significantly from that of the Receptor study that binding at the mutations of the amino acid and but their binding affinities for were significantly with that of the and binding but remains signaling. However, mutations of and remain with similar binding affinity with that of the with the binding the mutations of amino acid and significantly but and high and and are shown in of the substitutions of the conserved amino acid residues of hMC4R on binding and no with with with with no with with with with with with with no with no in a affinity and potency of at the mutations of the conserved amino acid residues of A the binding affinity of to B that the of at three Large Image Figure ViewerDownload Hi-res image Download (PPT) Mutations of in TM3 of the hMC4R for and substitution of TM3 of the hMC4R with the TM3 region of hMC2R significantly binding affinity and we that amino acid residues of TM3 of the hMC4R involved in The sequence of amino in TM3 between hMC4R and hMC2R was and in Fig. 1. A sequence alignment of hMC2R and hMC4R that amino acid residues are in To determine these amino acid residues are involved in binding and these residues were mutated with and Our results indicate that these mutant receptors were expressed at the cell surface and the expression levels no with that of the wild-type receptor binding at mutations and and their binding affinities were not significantly with that of However, mutation significantly binding affinity with that of with the binding mutations and did not significantly alter but mutation did and are shown in of the residues in TM3 of the hMC4R on binding and with with with receptor. in a have identified six conserved amino acid residues in the TMs of the hMC4R that are crucial for binding and signaling using both chimeric receptor and site-directed mutagenesis Glu100 in TM2, and Asp126 in TM3, Trp258, Phe261, and His264 in TM6 of the MC4R plays an important role in the regulation of both human and food The of the amino acid residues of the hMC4R responsible for MSH binding important information for the of the signaling that food intake and a basis for the of for the of studies have been performed to ligand receptor interaction between and MC4R based on the receptor model generated by computer (19Yang Y.K. Fong T.M. Dickinson C.J. Mao C. Li J.Y. Tota M.R. Mosley R. Van Der Ploeg L.H. Gantz I. Biochemistry. 2000; 39: 14900-14911Crossref PubMed Scopus (164) Google Scholar, 21Haskell-Luevano C. Cone R.D. Monck E.K. Wan Y.P. Biochemistry. 2001; 40: 6164-6179Crossref PubMed Scopus (138) Google Scholar, 24Pogozheva I.D. Chai B.X. Lomize A.L. Fong T.M. Weinberg D.H. Nargund R.P. Mulholland M.W. Gantz I. Mosberg H.I. Biochemistry. 2005; 44: 11329-11341Crossref PubMed Scopus (80) Google Scholar). However, the model for ligand receptor interaction has for of the ligand receptor The detailed information between and MC4R remains unclear. Both chimeric receptors and site-directed mutagenesis have been utilized for the molecular basis of the receptor responsible for ligand binding and signaling. The chimeric receptor is for domains of the receptors that are important for the of each receptor whereas site-directed mutagenesis studies are important for residues that are important for agonist antagonist binding Y. Chen M. Lai Y. Gantz I. Georgeson K.E. Harmon C.M. J. Biol. Chem. 2002; 277: 20328-20335Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar, Y.K. Dickinson C.J. Zeng Q. Li J.Y. Thompson D.A. Gantz I. J. Biol. Chem. 1999; 274: 14100-14106Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar, K. 2004; PubMed Scopus Google Scholar). In this study, we have each of these to determine the molecular basis of hMC4R responsible for binding and signaling. Melanocortin receptor subtypes are to have the molecular and we utilized hMC4R and hMC2R to chimeric receptors and determine the amino acid of the hMC4R involved in The hMC4R and hMC2R share a number of similarities. In the putative TM regions, hMC4R and hMC2R show overall identities of However, is a potent agonist for MC4R but not for MC2R. the conserved amino acid residues in TM2, TM3, and TM6 of hMC2R are crucial for ACTH binding and signaling that is similar to that of hMC4R, the chimeric receptor important information of ligand receptor that substitution of TM of the hMC4R with the region of the hMC2R results in the binding affinity and that residues are involved in binding and In substitution not alter binding affinity and that conserved residues are involved in Our results our that conserved residues in TMs of the hMC4R are crucial for binding and activity substitutions of the hMC4R TM regions with the regions of the hMC2R did not significantly or binding affinity and To determine which conserved of the hMC4R is involved in binding, we have the sequences of hMC4R and hMC2R and that amino in the TM2, TM3, and TM6 are conserved between hMC4R and hMC2R and these amino are for Site-directed mutagenesis studies of these conserved amino acid residues were the conserved amino acid residues have been identified to crucial for binding and signaling. residues are Glu100 in TM2, and Asp126 in TM3, and Trp258, Phe261, and His264 in TM6 of the and have been to involved in MSH binding and receptor at and amino acid residues are in ligand receptor interaction (19Yang Y.K. Fong T.M. Dickinson C.J. Mao C. Li J.Y. Tota M.R. Mosley R. Van Der Ploeg L.H. Gantz I. Biochemistry. 2000; 39: 14900-14911Crossref PubMed Scopus (164) Google Scholar, Y. Dickinson C. C. Gantz I. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar, C. S. J.A. C. Gantz I. Hruby V.J. Google Scholar). In this study, we have utilized chimeric receptors to the conserved residues between MC4R and MC2R involved in binding and signaling. Further mutagenesis studies the amino acid residues crucial for binding and signaling to to our results suggest that an binding in However, TM6 of the hMC4R to involved in a binding Mutations of the TM6 Trp258, Phe261, and binding affinity and receptor biological whereas the residues in and of the hMC4R not to an important role in binding and receptor biological Our results suggest that hMC4R binding with but have binding from that of have these results into the MC4R model and that both and are involved in MSH binding and receptor is by amino acid Glu100 in TM2, and and Asp126 in TM3, which are to form an interaction with of A binding is by three receptor Trp258, Phe261, and His264 in which are to form with of In conclusion, we have identified that Glu100 in TM2, and Asp126 in TM3, and Trp258, Phe261, and His264 in TM6 are important for binding and signaling. results important information about the molecular determinants of the hMC4R responsible for binding and signaling. Download with
Language: English
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W2000891355
FWCI: 1.279
Cites: 36
Cited by: 47
Related to: 10